Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001373706 | SCV001570436 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-06-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004601485 | SCV005099565 | uncertain significance | Inborn genetic diseases | 2024-05-20 | criteria provided, single submitter | clinical testing | The c.2699G>A (p.R900H) alteration is located in exon 19 (coding exon 19) of the CACNA1A gene. This alteration results from a G to A substitution at nucleotide position 2699, causing the arginine (R) at amino acid position 900 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |